tiprankstipranks
Genetic Technologies Sells geneType Business to Rhythm Biosciences
Company Announcements

Genetic Technologies Sells geneType Business to Rhythm Biosciences

Genetic Technologies (AU:GTG) has released an update.

Don't Miss Our Christmas Offers:

Genetic Technologies Limited has successfully completed the sale of its geneType business and assets to Rhythm Biosciences, marking a significant move in the genomic diagnostics sector. The transaction, finalized on December 23, 2024, involves a seamless transition with the support of both companies. This development reflects ongoing shifts in the market as companies adapt and restructure towards innovative growth.

For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskRhythm Biosciences Expands with Genetype Acquisition
TipRanks Australian Auto-Generated NewsdeskGenetic Technologies Defers Reports Amid Administration
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App